Manufacturing lyophilized oncological injectables need special sophistication regarding state-of-the-art equipments, highly expensive HVAC, most stringent environmental control systems and advanced formulation engineering. Due to the absence of technological know-how, Bangladesh was 100% dependent on the import of lyophilized anti-cancer drugs. Beacon has positioned itself to this particular market segment in order to be the first to manufacture life saving anti-cancer drugs in Bangladesh.

Beacon Pharma focuses on three strategic specialized therapy areas:

•  Cancer diseases

•  Hormone therapies

•  Cardiovascular diseases

Other life saving hi-tech general formulations will also be manufactured at Beacon.